BlackRock Fund Advisors’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$125K Buy
25,344
+768
+3% +$3.45K ﹤0.01% 3549
2016
Q3
$101K Sell
24,576
-27
-0.1% -$119 ﹤0.01% 3618
2016
Q2
$123K Sell
24,603
-7,473
-23% -$35.4K ﹤0.01% 3608
2016
Q1
$164K Sell
32,076
-2,578
-7% -$14K ﹤0.01% 3536
2015
Q4
$224K Sell
34,654
-3,882
-10% -$25.6K ﹤0.01% 3486
2015
Q3
$227K Sell
38,536
-1,020
-3% -$4.56K ﹤0.01% 3424
2015
Q2
$166K Sell
39,556
-1,566
-4% -$6.36K ﹤0.01% 3596
2015
Q1
$161K Sell
41,122
-2,784
-6% -$9.62K ﹤0.01% 3533
2014
Q4
$137K Buy
43,906
+3,132
+8% +$9.62K ﹤0.01% 3561
2014
Q3
$132K Sell
40,774
-2,958
-7% -$10.2K ﹤0.01% 3592
2014
Q2
$168K Buy
43,732
+1,248
+3% +$4.78K ﹤0.01% 3545
2014
Q1
$181K Buy
42,484
+5,148
+14% +$19.8K ﹤0.01% 3493
2013
Q4
$133K Buy
37,336
+1,560
+4% +$5.83K ﹤0.01% 3531
2013
Q3
$143K Buy
35,776
+2,808
+9% +$10.6K ﹤0.01% 3486
2013
Q2
$117K Buy
+32,968
New +$129K ﹤0.01% 3489

Other funds holding ULBI

BlackRock Fund Advisors's ULBI Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Ultralife (ULBI) stake by 3.1% in Q4 2016, buying an estimated $3.45K and bringing the position to 25,344 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #3549.

BlackRock Fund Advisors first reported a position in ULBI in Q2 2013 and has held it in 15 quarters since. The position peaked at $227K in Q3 2015. 37 funds tracked by Wall St. Rank hold ULBI as of Q4 2016.

  • BlackRock Fund Advisors held 25,344 shares of Ultralife worth $125K as of Q4 2016.
  • BlackRock Fund Advisors bought 768 Ultralife shares in Q4 2016, an estimated $3.45K.
  • Ultralife made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3549 holding.
  • BlackRock Fund Advisors first reported a position in Ultralife in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Ultralife position peaked at $227K in Q3 2015.
  • 37 funds tracked by Wall St. Rank held Ultralife as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.